Akari Therapeutics (AKTX) Share-based Compensation (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -89.35% |
| Dec 31, 2025 | -449.20% |
| Sep 30, 2025 | -4.73% |
| Jun 30, 2025 | -29.16% |
| Mar 31, 2025 | -19.19% |
| Dec 31, 2024 | 406.45% |
| Sep 30, 2024 | -44.27% |
| Jun 30, 2024 | 50.34% |
| Mar 31, 2024 | 142.05% |
| Dec 31, 2023 | -330.82% |
| Sep 30, 2023 | 10.51% |
| Jun 30, 2023 | 4.15% |
| Jun 30, 2022 | 24.30% |
| Mar 31, 2022 | 100.00% |
| Dec 31, 2021 | -200.00% |
| Sep 30, 2021 | 289,401,903.61% |
| Jun 30, 2021 | -3.29% |
| Mar 31, 2021 | 100.00% |
| Dec 31, 2020 | -200.00% |
| Sep 30, 2020 | 343.71% |
| Jun 30, 2020 | -200.00% |
| Mar 31, 2020 | 94,867,798.17% |
| Dec 31, 2019 | -22.89% |
| Sep 30, 2019 | -66.46% |
| Jun 30, 2019 | 3.85% |
| Mar 31, 2019 | -5.49% |
| Dec 31, 2018 | 3.36% |
| Sep 30, 2018 | 14.71% |
| Jun 30, 2018 | -26.05% |
| Mar 31, 2018 | -5.93% |
| Dec 31, 2017 | 5.11% |
| Sep 30, 2017 | -41.62% |
| Jun 30, 2017 | -10.68% |
| Mar 31, 2017 | -28.31% |
| Dec 31, 2016 | 25.85% |
| Sep 30, 2016 | 27.05% |
| Jun 30, 2016 | -1.40% |
| Mar 31, 2016 | 282.03% |
| Dec 31, 2015 | -74.12% |
| Jun 30, 2014 | -20.00% |